GN STORE NORD Total Assets 2016-2020 | GNNDY

GN STORE NORD total assets from 2016 to 2020. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • GN STORE NORD total assets for the quarter ending March 31, 2020 were $2.280B, a 6.62% increase year-over-year.
  • GN STORE NORD total assets for 2019 were $2.501B, a 21.29% increase from 2018.
  • GN STORE NORD total assets for 2018 were $2.062B, a 15.65% increase from 2017.
  • GN STORE NORD total assets for 2017 were $1.783B, a 6.52% decline from 2016.
GN STORE NORD Annual Total Assets
(Millions of US $)
2019 $2,501
2018 $2,062
2017 $1,783
2016 $1,907
2015 $1,663
GN STORE NORD Quarterly Total Assets
(Millions of US $)
2020-03-31 $2,280
2019-12-31 $2,501
2019-09-30 $2,201
2019-06-30 $2,137
2019-03-31 $2,139
2018-12-31 $2,062
2018-09-30 $1,951
2018-06-30 $1,936
2018-03-31 $1,766
2017-12-31 $1,783
2017-09-30 $1,795
2017-06-30 $1,693
2017-03-31 $1,679
2016-12-31 $1,907
2016-09-30 $1,790
2016-06-30 $1,682
2016-03-31 $1,609
2015-12-31 $1,663
2015-09-30 $0
2015-06-30 $0
2015-03-31 $0
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $9.996B $1.886B
GN Store Nord A/S offers medical hearing instruments, professional and consumer headsets. The Company's operating segments include GN Netcom, GN ReSound and Others. GN Netcom segment sells hands-free communications solutions in the form of headsets for mobile phones and traditional phones. GN ReSound segment operates within the hearing instrument industry, and produces and sells hearing healthcare instruments and related products. It offers hearing aids and accessories under the ReSound, Beltone and Interton brand names. GN Store Nord A/S is based in Ballerup, Denmark.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $190.845B 34.22
Medtronic (MDT) Ireland $149.772B 28.21
Stryker (SYK) United States $83.174B 32.25
Boston Scientific (BSX) United States $53.178B 30.72
Lonza Group Ag (LZAGY) Switzerland $47.347B 0.00
Baxter (BAX) United States $41.050B 0.00
EssilorLuxottica Societe Anonyme (ESLOY) France $30.025B 0.00
Zimmer Biomet Holdings (ZBH) United States $29.548B 24.52
Terumo (TRUMY) Japan $28.364B 36.26
ResMed (RMD) United States $26.523B 38.45
Sunny Optical Technology (SNPTF) China $17.297B 0.00
Bio-Rad Laboratories (BIO) United States $17.264B 78.08
Smith & Nephew SNATS (SNN) United Kingdom $16.848B 0.00
Insulet (PODD) United States $16.373B 692.75
DiaSorin S.p.A (DSRLF) Italy $12.588B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $11.080B 0.00
Quidel (QDEL) United States $10.412B 55.16
William Demant Holdings (WILYY) Denmark $8.193B 0.00
Canopy Growth (CGC) Canada $7.335B 0.00
Perrigo (PRGO) Ireland $6.226B 10.68
Hill-Rom Holdings (HRC) United States $6.153B 15.27
Haemonetics (HAE) United States $5.422B 36.13
Envista Holdings (NVST) United States $4.406B 30.04
Hutchison China MediTech (HCM) Hong Kong, SAR China $4.095B 0.00
ICU Medical (ICUI) United States $4.037B 30.80
Abcam (ABCZY) $3.853B 0.00
Neogen (NEOG) United States $3.834B 62.86
National Vision Holdings (EYE) United States $3.469B 539.13
TG Therapeutics (TGTX) United States $3.420B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $2.949B 0.00
NuVasive (NUVA) United States $2.684B 37.40
Agios Pharmaceuticals (AGIO) United States $2.629B 0.00
DFB Healthcare Acquisitions (AHCO) United States $2.406B 0.00
AtriCure (ATRC) United States $1.706B 0.00
Owens & Minor (OMI) United States $1.627B 36.44
Cardiovascular Systems (CSII) United States $1.568B 0.00
NanoString Technologies (NSTG) United States $1.372B 0.00
InMode (INMD) Israel $1.327B 33.46
Aphria (APHA) Canada $1.314B 0.00
MacroGenics (MGNX) United States $1.195B 0.00
Quanterix (QTRX) United States $1.154B 0.00
OraSure Technologies (OSUR) United States $1.067B 0.00
Cerus (CERS) United States $1.054B 0.00
BioLife Solutions (BLFS) United States $0.929B 483.67
PetIQ (PETQ) United States $0.871B 24.98
Lantheus Holdings (LNTH) United States $0.864B 11.97
Vapotherm (VAPO) United States $0.814B 0.00
Meridian Bioscience (VIVO) United States $0.786B 18.15
Phibro Animal Health (PAHC) United States $0.739B 16.93
LeMaitre Vascular (LMAT) United States $0.664B 40.52
Eagle Pharmaceuticals (EGRX) United States $0.637B 90.04
Omeros (OMER) United States $0.581B 0.00
Surmodics (SRDX) United States $0.557B 61.08
Varex Imaging (VREX) United States $0.555B 24.05
Aurora Cannabis (ACB) Canada $0.540B 0.00
Zynex (ZYXI) United States $0.502B 43.85
Surface Oncology (SURF) United States $0.382B 0.00
Viemed Healthcare (VMD) United States $0.372B 13.22
HEXO (HEXO) $0.372B 0.00
Cytosorbents (CTSO) United States $0.358B 0.00
Utah Medical Products (UTMD) United States $0.309B 26.54
SEMPERIT AG HLD (SEIGY) Austria $0.257B 0.00
Organigram Holdings (OGI) Canada $0.245B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.216B 0.00
Bovie Medical (APYX) United States $0.214B 0.00
Wound Management Technologies (SMTI) United States $0.191B 0.00
Exagen (XGN) United States $0.185B 0.00
Chimerix (CMRX) United States $0.175B 0.00
Female Health (VERU) United States $0.172B 0.00
Fonar (FONR) United States $0.138B 18.29
Liberty Health Sciences (LHSIF) United States $0.130B 0.00
Evolus (EOLS) United States $0.118B 0.00
Chembio Diagnostics (CEMI) United States $0.099B 0.00
Capricor Therapeutics (CAPR) United States $0.088B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.076B 0.00
United-Guardian (UG) United States $0.068B 15.31
Rockwell Medical (RMTI) United States $0.067B 0.00
Brainsway (BWAY) Israel $0.067B 0.00
Trinity Biotech (TRIB) Ireland $0.065B 12.23
Nephros (NEPH) United States $0.062B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.060B 0.00
MTech Acquisition (KERN) United States $0.055B 0.00
ImmuCell (ICCC) United States $0.041B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.024B 0.00
FSD PHARMA INC (HUGE) Canada $0.024B 0.00
NF Energy Saving (BIMI) China $0.023B 0.00
Akers Biosciences Inc (AKER) United States $0.019B 0.00
GUARDION HEALTH (GHSI) United States $0.017B 0.00
NeuroMetrix (NURO) United States $0.006B 0.00
Senestech (SNES) United States $0.006B 0.00